Neideen Todd, Lam Michelle, Brasel Karen J
Division of Trauma/Critical Care, Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
J Trauma. 2008 Nov;65(5):1016-20. doi: 10.1097/TA.0b013e3181897eac.
Beta-blockade decreases mortality and morbidity in selected older patient populations undergoing noncardiac general surgery. We hypothesized that preinjury beta blockade would increase mortality in geriatric trauma patients, given beta-blockers inhibit patient's physiologic responses to hypovolemic shock.
Patients older than 65 years admitted to a level I trauma center were identified by the trauma registry. Medical records were reviewed for demographic and injury information. Preinjury beta blockade was determined by review of nurse and pharmacy admission histories. Logistic regression was used to determine whether there was any correlation between mortality and the use of preinjury beta blockers. Separate models were developed based on the presence or the absence of head injury.
Of the 1,598 patients older than 65 years admitted between 1996 and 2006, 1,479 met inclusion criteria. Primary reason for exclusion was lack of documentation. Two hundred seventy-three patients were taking beta blockers before their trauma, and 14.7% died before discharge. Mortality in patients not taking beta blockers was 13.4%. Mortality in patients with head injury was 25.9%, significantly associated with warfarin use (OR 2.5, 95% CI 1.3-4.8). In patients without head injury, preinjury beta blockade had a significant association with mortality (OR 2.1, 95% CI 1.1-4.3).
Many factors associated with mortality in elderly trauma patients are similar to the younger patient population. Unique to this population are increased comorbidities and use of prescription medications. Beta blockers, one of these common medications, are associated with increased mortality in the elderly.
β受体阻滞剂可降低特定老年非心脏普外科手术患者的死亡率和发病率。我们推测,鉴于β受体阻滞剂会抑制患者对低血容量性休克的生理反应,伤前使用β受体阻滞剂会增加老年创伤患者的死亡率。
通过创伤登记系统识别入住一级创伤中心的65岁以上患者。查阅病历以获取人口统计学和损伤信息。通过查阅护士和药房的入院记录确定伤前是否使用β受体阻滞剂。采用逻辑回归分析确定死亡率与伤前使用β受体阻滞剂之间是否存在关联。根据有无头部损伤建立了不同的模型。
在1996年至2006年间收治的1598例65岁以上患者中,1479例符合纳入标准。排除的主要原因是缺乏记录。273例患者在创伤前服用β受体阻滞剂,其中14.7%在出院前死亡。未服用β受体阻滞剂患者的死亡率为13.4%。头部损伤患者的死亡率为25.9%,与使用华法林显著相关(比值比2.5,95%可信区间1.3 - 4.8)。在无头部损伤的患者中,伤前使用β受体阻滞剂与死亡率显著相关(比值比2.1,95%可信区间1.1 - 4.3)。
老年创伤患者中许多与死亡率相关的因素与年轻患者群体相似。该群体特有的情况是合并症增加和使用处方药。β受体阻滞剂作为这些常用药物之一,与老年人死亡率增加有关。